STERIS Acquires Coon Rapids Medical Offices For $13.1 Million, Bolstering Minnesota Presence

STERIS Acquires Coon Rapids Medical Offices For $13.1 Million, Bolstering Minnesota Presence

Coon Rapids, MN  – STERIS plc (NYSE: STE), a leading global provider of infection prevention and other procedural products and services, has acquired a 100,000 square-foot medical office space in Coon Rapids, Minnesota, for $13.1 million. This transaction further strengthens STERIS's footprint in the crucial Minnesota "Medical Alley" region, a hub for medical device manufacturing and healthcare innovation.

While specific details about the exact closing date of this transaction are pending wider public release, the acquisition aligns with STERIS's established strategy of expanding its physical assets and service capabilities in key healthcare markets. The company has a long history of strategic investments in Minnesota. For instance, STERIS AST (Applied Sterilization Technologies) operates a significant laboratory in Brooklyn Park, Minnesota, which expanded its product and packaging testing services in November 2021 (with services becoming available in March 2023), demonstrating a commitment to supporting the region's robust medical device industry. Furthermore, STERIS has had a presence in Minnesota's contract sterilization sector since acquiring Quality Sterilization Services (QSS) near Minneapolis in July 1999.

This latest real estate investment reflects STERIS's continued commitment to supporting healthcare providers and medical device manufacturers with a comprehensive portfolio of solutions, from sterilization services and surgical instruments to infection prevention products. The company's continued investment in Coon Rapids, a growing community with a significant healthcare sector including facilities like Mercy Hospital and various clinics, underscores its dedication to meeting the evolving needs of the medical community.

STERIS, headquartered in Dublin, Ireland, with operational headquarters in Mentor, Ohio, consistently pursues growth through strategic acquisitions. Notable past acquisitions include the surgical instrumentation assets from BD for $540 million, announced in June 2023 and completed in August 2023, and Cantel Medical for approximately $4.6 billion (enterprise value), with a definitive agreement announced in January 2021 and the transaction expected to close by the end of STERIS's first fiscal quarter of 2022 (ending June 30, 2021). These moves highlight the company's focus on expanding its offerings within its core markets of healthcare, pharmaceuticals, and medtech.

This Coon Rapids acquisition signifies STERIS's continued confidence in the regional healthcare market and its dedication to providing essential services that help customers create a healthier and safer world.

MinneapoliMedia